ArticleJAMA network open2025

Cost-Effectiveness and Evidence Gaps Surrounding PSMA-PET for Recurrent Prostate Cancer Evaluation.

Natalia Kunst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.